RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...

Researchers at the University of Toronto and its hospital partners have developed a method for co-delivering therapeutic RNA and potent drugs directly into cells, potentially leading to a more ...

Since its discovery in 1998 and winning the Nobel Prize in 2006, ribonucleic acid (RNA) interference has become an invaluable tool for drugmakers to silence disease-causing genes. Nearly three decades ...

Preclinical data shows use of megalin receptors for intracellular delivery of a ligand-siRNA conjugate to silence production of target mRNA in the kidney Megalin-binding genetic medicines are ...

A startup focused on developing oligonucleotide-based silent RNA treatments for systemic and renal diseases is emerging from stealth mode, launching with $100 million in combined seed and ...

A formamide modification (yellow) to a therapeutic agent siRNA (blue) prevents siRNA to bind to non-target mRNA, which allows for treatment with less side effects. Small interfering RNA (siRNA) drugs ...

Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune ...

CAMBRIDGE, Mass., May 14, 2026 /PRNewswire/ -- Ring Therapeutics®, a life sciences company pioneering a new class of targeted medicines, today announced new data on its Vector Conjugate platform and ...